» Articles » PMID: 3009377

Amplifications of Both C-Ki-ras with a Point Mutation and C-myc in a Primary Pancreatic Cancer and Its Metastatic Tumors in Lymph Nodes

Overview
Specialty Oncology
Date 1986 Apr 1
PMID 3009377
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

Activated c-Ki-ras with a point mutation (GGT to CGT) at codon 12, resulting in the substitution of arginine for glycine, was found in DNA from metastatic pancreatic adenocarcinoma in a lymph node. By means of restriction endonuclease length polymorphism with SacI digestion, we were able to demonstrate that the same point mutation of c-Ki-ras was present in the primary tumor and in metastases in lymph nodes. DNA from the normal spleen of the patient did not have this type of point mutation. Moreover, amplifications of 3- to 6-fold of the activated c-Ki-ras and 50-fold of c-myc were found in the primary tumor and the metastases in the two lymph nodes, indicating that point mutation had occurred at a relatively early stage of the tumor development, before amplification of the gene. This is the first clear demonstration of amplification of activated c-Ki-ras accompanied by amplification of c-myc in both primary and metastatic human tumors in vivo.

Citing Articles

Context Matters-Why We Need to Change From a One Size Fits all Approach to Made-to-Measure Therapies for Individual Patients With Pancreatic Cancer.

Sankarasubramanian S, Pfohl U, Regenbrecht C, Reinhard C, Wedeken L Front Cell Dev Biol. 2021; 9:760705.

PMID: 34805167 PMC: 8599957. DOI: 10.3389/fcell.2021.760705.


Evolutionary routes and KRAS dosage define pancreatic cancer phenotypes.

Mueller S, Engleitner T, Maresch R, Zukowska M, Lange S, Kaltenbacher T Nature. 2018; 554(7690):62-68.

PMID: 29364867 PMC: 6097607. DOI: 10.1038/nature25459.


KRAS mutant allele-specific imbalance is associated with worse prognosis in pancreatic cancer and progression to undifferentiated carcinoma of the pancreas.

Krasinskas A, Moser A, Saka B, Adsay N, Chiosea S Mod Pathol. 2013; 26(10):1346-54.

PMID: 23599154 PMC: 4128625. DOI: 10.1038/modpathol.2013.71.


Rare codons regulate KRas oncogenesis.

Lampson B, Pershing N, Prinz J, Lacsina J, Marzluff W, Nicchitta C Curr Biol. 2012; 23(1):70-5.

PMID: 23246410 PMC: 3567844. DOI: 10.1016/j.cub.2012.11.031.


Pancreatic ductal adenocarcinoma and transcription factors: role of c-Myc.

Skoudy A, Hernandez-Munoz I, Navarro P J Gastrointest Cancer. 2011; 42(2):76-84.

PMID: 21279552 DOI: 10.1007/s12029-011-9258-0.